Nanoparticle measuring
A team of scientists from Taiwan has developed a nanoparticle/virus mass spectrometry technique to make rapid and accurate mass and mass distribution measurements of nanoparticles and viruses.
A team of scientists from Taiwan has developed a nanoparticle/virus mass spectrometry technique to make rapid and accurate mass and mass distribution measurements of nanoparticles and viruses.1 The team had previously developed a technique that allowed them to measure the mass of a cell or a microparticle.
The method used was laser-induced acoustic desorption (LIAD) and the team was able to take measurements within 1 min.
The team concluded that their research has potential for the quality control of nanoparticle production, where differences in size can affect the properties, and the identification of various viruses. The method could be used in the future to monitor drug delivery when nanoparticles are used as carriers. It could also be possible to measure the degree of infection by measuring the number of viruses in specific cells or in plasma.
1. Chung-Hsuan Chen et al., Analytical Chemistry, 84(11), 4965–4969 (2012).
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
